![Douglas Loh](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Loh
Corporate Officer/Principal presso
Australia Institute of Co. Directors
Patrimonio netto: 1 M $ in data 31/05/2026
Profilo
Douglas Loh is currently a Member at the Australia Institute of Co. Directors.
Former roles include Chief Financial Officer at Biome Australia Ltd. from 2021 to 2026, Non-Executive Chairman at DXN Ltd. from 2019 to 2020, Executive Director at Pulse Health Ltd. from 2013 to 2016, Director at Health Science Innovation Holdings Pty Ltd. from 2013 to 2016, and Chief Operating Officer at Acorn Capital Ltd. from 1998 to 2017.
Education includes an undergraduate degree from Monash University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
BIOME AUSTRALIA LTD 3,83% | 10/06/2026 | 8.739.288 ( 3,83% ) | 1 M $ | 31/05/2026 |
Posizioni attive di Douglas Loh
| Società | Posizione | Inizio |
|---|---|---|
Australia Institute of Co. Directors | Corporate Officer/Principal | - |
Precedenti posizioni note di Douglas Loh
| Società | Posizione | Fine |
|---|---|---|
| BIOME AUSTRALIA LIMITED | Direttore Finanziario/CFO | 02/02/2026 |
| DXN LIMITED | Presidente | 17/03/2020 |
Acorn Capital Ltd.
 Acorn Capital Ltd. Investment ManagersFinance Acorn Capital is a fundamental-oriented manager which seeks to generate long-term outperformance through its distinctive research and investment capabilities and to identify attractive opportunities in less efficient markets. They target the management of small to emerging company portfolios for clients. The firm's investment philosophy is based on its belief that there are pricing inefficiencies amongst Emerging Companies due to a lack of readily available external research conducted on such entities. They believe that through a research driven investment process the inefficiencies that exist in Emerging Companies can be exploited to earn superior returns. | Direttore operativo | 01/12/2017 |
| PULSE HEALTH LIMITED | Direttore/Membro del Consiglio | 01/01/2016 |
Health Science Innovation Holdings Pty Ltd. | Direttore/Membro del Consiglio | 01/01/2016 |
Formazione di Douglas Loh
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
73
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Pulse Health Ltd.
 Pulse Health Ltd. Medical/Nursing ServicesHealth Services Acquires and operates private hospitals and related health care services | Health Services |
Acorn Capital Ltd.
Acorn Capital Ltd. Investment ManagersFinance Acorn Capital is a fundamental-oriented manager which seeks to generate long-term outperformance through its distinctive research and investment capabilities and to identify attractive opportunities in less efficient markets. They target the management of small to emerging company portfolios for clients. The firm's investment philosophy is based on its belief that there are pricing inefficiencies amongst Emerging Companies due to a lack of readily available external research conducted on such entities. They believe that through a research driven investment process the inefficiencies that exist in Emerging Companies can be exploited to earn superior returns. | Finance |
Monash University
 Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Australia Institute of Co. Directors | |
DXN Ltd.
 DXN Ltd. Data Processing ServicesTechnology Services Designs, builds, owns and operates data centres | Technology Services |
Health Science Innovation Holdings Pty Ltd. | |
Biome Australia Ltd.
 Biome Australia Ltd. Pharmaceuticals: MajorHealth Technology Develops and markets evidence-based complementary medicines, nutraceuticals & live bio-therapeutics | Health Technology |
